Literature DB >> 11864917

Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury.

Hakuoh Konishi1, Youichi Katoh, Norihide Takaya, Yuji Kashiwakura, Seigo Itoh, Chisei Ra, Hiroyuki Daida.   

Abstract

BACKGROUND: Platelet adhesion on components of the extracellular matrix and platelet activation by those components are crucial for the arrest of posttraumatic bleeding, but they can also harm tissue by occluding diseased vessels. Recent studies have shown that the activation of platelets by collagen is mediated through the same pathway used by immune receptors, with an immunoreceptor tyrosine-based activation motif on the Fc receptor gamma chain (FcRgamma) playing a pivotal role. METHODS AND
RESULTS: We examined the role of collagen-stimulated platelets in the development of injury-induced neointimal formation by using mice deficient in FcRgamma. The left femoral arteries of 8- to 12-week-old FcRgamma-deficient mice (n=16) and C57BL/6 (wild-type) mice (n=16) were injured by a straight spring wire (0.35-mm diameter). Segments of the injured and uninjured femoral arteries were excised at 7 days and 28 days after the vascular injury. Arterial segments were examined by immunohistochemistry and electron microscopy. Two hours after injury, electron microscopy showed marked decreases in platelet adhesion and neutrophil attachment to the vascular wall surface in FcRgamma-knockout mice compared with wild-type mice. At 7 days after injury, staining with anti-neutrophil antibody showed fewer neutrophils in FcRgamma-knockout mice than in wild-type mice. Computer-aided morphometry performed to measure the neointimal area, intima/media ratio, and stenotic area at 28 days after injury showed a significantly smaller ratio and area in FcRgamma-knockout mice than in wild-type mice (for neointimal area, 16 635 +/- 1406 versus 31 483 +/- 2309 microm2, respectively; for intima/media ratio, 1.25 +/- 0.40 versus 2.68 +/- 0.04, respectively; and for stenotic area, 26.8 +/- 2.1% versus 49.3 +/- 4.1%, respectively).
CONCLUSIONS: These results demonstrate that FcRgamma may play important roles in the initiation and generation of neointimal hyperplasia after balloon injury through the activation of platelets by collagen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864917     DOI: 10.1161/hc0802.105256

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies.

Authors:  J J Shatzel; S R Olson; D L Tao; O J T McCarty; A V Danilov; T G DeLoughery
Journal:  J Thromb Haemost       Date:  2017-03-27       Impact factor: 5.824

Review 2.  Platelet receptor signaling in thrombus formation.

Authors:  David Stegner; Bernhard Nieswandt
Journal:  J Mol Med (Berl)       Date:  2010-11-07       Impact factor: 4.599

Review 3.  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Authors:  Lutz Tautz; Yotis A Senis; Cécile Oury; Souad Rahmouni
Journal:  Bioorg Med Chem       Date:  2015-04-04       Impact factor: 3.641

Review 4.  Fcγ receptors and ligands and cardiovascular disease.

Authors:  Keiji Tanigaki; Nathan Sundgren; Amit Khera; Wanpen Vongpatanasin; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

5.  Antiatherosclerotic effects of the Fc portion of immunoglobulin in apolipoprotein E-deficient mice.

Authors:  Chiharu Kishimoto; Zuyi Yuan; Hideto Sano; Keisuke Shioji; Yang Xu; Masayuki Yokode
Journal:  Exp Clin Cardiol       Date:  2004

Review 6.  Platelets influence vascularized organ transplants from start to finish.

Authors:  A D Kirk; C N Morrell; W M Baldwin
Journal:  Am J Transplant       Date:  2008-11-27       Impact factor: 8.086

7.  Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.

Authors:  Lucia Musumeci; Marijke J Kuijpers; Karen Gilio; Alexandre Hego; Emilie Théâtre; Lisbeth Maurissen; Maud Vandereyken; Catia V Diogo; Christelle Lecut; William Guilmain; Ekaterina V Bobkova; Johannes A Eble; Russell Dahl; Pierre Drion; Justin Rascon; Yalda Mostofi; Hongbin Yuan; Eduard Sergienko; Thomas D Y Chung; Marc Thiry; Yotis Senis; Michel Moutschen; Tomas Mustelin; Patrizio Lancellotti; Johan W M Heemskerk; Lutz Tautz; Cécile Oury; Souad Rahmouni
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

Review 8.  Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine.

Authors:  Yunfeng Chen; Lining Arnold Ju
Journal:  Stroke Vasc Neurol       Date:  2019-12-15

9.  Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients.

Authors:  Min Zhang; Jiangrong Wang; Yong Zhang; Pei Zhang; Zhisheng Jia; Manyi Ren; Xiaomeng Jia; Liping Ma; Mei Gao; Yinglong Hou
Journal:  Drug Des Devel Ther       Date:  2020-02-19       Impact factor: 4.162

10.  Proteolytic processing of platelet receptors.

Authors:  Elizabeth E Gardiner
Journal:  Res Pract Thromb Haemost       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.